MedPath

A randomised controlled clinical trial to compare the effects of injectable sodium valproate with injectable phenytoin in children having acute seizures.

Phase 4
Conditions
Health Condition 1: null- acute seizures
Registration Number
CTRI/2013/10/004081
Lead Sponsor
Department of PediatricsGovt Multispeciality hospital Sector Chandigarh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
134
Inclusion Criteria

Presenting with either of following :

A clinical features of Motor seizures (generalized or focal ) in active stage at Pediatric Emergency ,

Patients with acute repetitive seizures ( two or more episodes of seizures in last 12 hours.

Exclusion Criteria

1. <2 years and >12 years

2. already on antiepileptic drugs

3. children with head trauma

4. very sick child with shock or impending respiratory failure.

5. Known hypersensitive to phenytoin/ Valproate

6. Known liver disease or clinically icteric.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Seizure control and recurrences of seizure for 24 hour period between the two groups <br/ ><br> <br/ ><br>Timepoint: Seizure control and recurrences of seizure for 24 hour period between the two groups <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1. time taken to control seizures. <br/ ><br>2. variation in cardiorespiratory parameters. <br/ ><br>3. time to regain consciousness <br/ ><br>4. any adverse effectsTimepoint: vital monitoring at admission, 15 min, 30 min, 1 hr, 6hr, 12 hr and 24 hr.
© Copyright 2025. All Rights Reserved by MedPath